Robert Wasserman
Stock Analyst at Benchmark
(2.10)
# 2,624
Out of 4,818 analysts
117
Total ratings
38.24%
Success rate
-8.31%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XOMA XOMA Royalty | Initiates: Buy | $35 | $23.34 | +49.96% | 1 | Apr 17, 2025 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $3 | $0.44 | +575.68% | 6 | Apr 1, 2025 | |
| KMDA Kamada | Initiates: Buy | $15 | $6.60 | +127.27% | 1 | Mar 21, 2025 | |
| OABI OmniAb | Maintains: Buy | $8 → $6 | $1.86 | +223.45% | 8 | Mar 20, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $2.54 | - | 6 | Mar 3, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $140 → $150 | $120.49 | +24.49% | 10 | Feb 21, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $75 | $58.43 | +28.36% | 8 | Feb 20, 2025 | |
| LGND Ligand Pharmaceuticals | Reiterates: Buy | $135 | $106.00 | +27.36% | 10 | Dec 23, 2024 | |
| BLFS BioLife Solutions | Reiterates: Buy | $30 | $24.39 | +23.00% | 6 | Dec 19, 2024 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Speculative Buy | $8 | $0.97 | +724.74% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.86 | +168.82% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $5.01 | +139.52% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.27 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $95 | $50.18 | +89.32% | 5 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $141.46 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $12 | $1.30 | +823.08% | 6 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $33.86 | +32.90% | 6 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $3.50 | +14.29% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $0.25 | +1,531.32% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $1.59 | +4,616.98% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $196.31 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $431.64 | +34.37% | 1 | Jul 16, 2021 |
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $23.34
Upside: +49.96%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $0.44
Upside: +575.68%
Kamada
Mar 21, 2025
Initiates: Buy
Price Target: $15
Current: $6.60
Upside: +127.27%
OmniAb
Mar 20, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.86
Upside: +223.45%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $2.54
Upside: -
Integer Holdings
Feb 21, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $120.49
Upside: +24.49%
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $58.43
Upside: +28.36%
Ligand Pharmaceuticals
Dec 23, 2024
Reiterates: Buy
Price Target: $135
Current: $106.00
Upside: +27.36%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $24.39
Upside: +23.00%
Anebulo Pharmaceuticals
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $0.97
Upside: +724.74%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.86
Upside: +168.82%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $5.01
Upside: +139.52%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $2.27
Upside: -
Aug 13, 2024
Reiterates: Buy
Price Target: $95
Current: $50.18
Upside: +89.32%
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $141.46
Upside: -
Jul 11, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $1.30
Upside: +823.08%
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $33.86
Upside: +32.90%
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $3.50
Upside: +14.29%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $0.25
Upside: +1,531.32%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $1.59
Upside: +4,616.98%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $196.31
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $431.64
Upside: +34.37%